Plus the adult SR-aGvHD trial that will more likely get the FDA green light as the potency assay has been sorted out. Let’s not forget that the market for adult SR-aGvHD is 5 times bigger than the paediatric one.
Plus the adult SR-aGvHD trial that will more likely get the FDA...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
-0.005(0.44%) |
Mkt cap ! $1.275B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.14 | $1.11 | $1.936M | 1.727M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 47391 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43471 | 15 |
View Market Depth
| Last trade - 14.13pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
-0.005 ( 2.55 %) |
||||
| Open | High | Low | Volume | ||
| $1.13 | $1.14 | $1.10 | 606618 | ||
| Last updated 14.33pm 05/06/2024 ? | |||||
| MSB (ASX) Chart |